Repurposed drug may boost liver transplant success
An existing drug could protect donor livers from damage during the transplantation process and reduce complications that occur afterwards, a study suggests.
Dec 21, 2022
0
31
An existing drug could protect donor livers from damage during the transplantation process and reduce complications that occur afterwards, a study suggests.
Dec 21, 2022
0
31
The age, sex, and other demographic information about a patient can be used to predict whether they will need to be readmitted following a liver transplant, according to new research spearheaded by recent Penn State graduate ...
Dec 16, 2022
0
1
HKUMed researchers at AIDS Institute, Department of Microbiology and Department of Surgery, School of Clinical Medicine, and School of Biomedical Sciences have discovered the role of an isoformic programmed cell death protein ...
Dec 8, 2022
0
10
A rare parasitic disease that has long been documented in Europe seems to have taken root in the United States.
Nov 17, 2022
0
14
Disruptions in the gut microbiome have been linked to lower survival rates for people who have undergone kidney and liver transplants, a finding that highlights the critical importance of the vast and complex microbial communities ...
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. In Germany, there are currently around 9,000 new HCC diagnoses per year, and almost 8,000 people affected do not survive the disease. Before the ...
Oct 19, 2022
0
57
The liver is known for its ability to regenerate. It can completely regrow itself even after two-thirds of its mass has been surgically removed. But damage from medications, alcohol abuse or obesity can eventually cause the ...
Oct 17, 2022
0
7
There is a small, but growing, subset of livers that have been transplanted and have a cumulative age of more than 100 years, according to researchers from University of Texas (UT) Southwestern Medical Center, Dallas, and ...
Oct 16, 2022
0
5
Demand for donor livers for transplant patients outstrips supply with over 15% of waitlist patients dying after a year. A new international study offers support for increasing the use of living donor liver transplantation ...
Sep 26, 2022
0
18
A physician-scientist at City of Hope, one of the largest cancer research and treatment organizations in the United States, has identified a novel combination immunotherapy regimen that demonstrated significant response in ...
Sep 12, 2022
0
11